Her risks were assessed through a tool called Neurocognitive Adaption with 140 questions about the various activities she has ...
Seven million Americans live with this disease — undermining the hunt for a cure is a blow to them and their families.
STOCKHOLM, SWEDEN / ACCESS Newswire / February 27, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its Year-end report for the period Januar ...
The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the year-end report for the period January - December, and the fourth quarter, 2024. The full report, which is atta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results